The Agency for UK REACH has published final opinions on the following applications for authorisation.

• Reference: AFA014-01
  Applicant: Roche Diagnostics Limited
  Substances: 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (Octylphenolethoxylates, OPnEO) and 4-Nonylphenol, branched and linear, ethoxylated (Nonylphenolethoxylates, NPnEO) 
  Use: Use of OPnEO and NPnEO in 10 in vitro diagnostic (IVD) assays used for example in Clinical Chemistry (CC) and Drug Monitoring (DM) products.
  
  HSE sent the final opinion to the Appropriate Authorities on 20 September 2023.
  
  
• Reference: AFA015-01
  Applicant: Bonaprene Products Limited
  Substance: 2,2'-dichloro-4,4'-methylenedianiline (MOCA, MbOCA) (EC: 202-918-9, CAS: 101-14-4)
  Use: MbOCA is used as a reactant in the manufacture of cast polyurethanes at an industrial site.
  
  HSE sent the final opinion to the Appropriate Authorities on 11 October 2023.
  
  
• Reference: AFA017-01
  Applicant: Becton, Dickinson U.K. Limited
  Substance: 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) (EC: 247-384-8, CAS: 25973-55-1)
  Use: Use of an imported polymer containing UV-328 as an additive for UV stabilisation in the manufacture of a mechanical separator component used in Barricor blood collection tubes.
  
  HSE sent the final opinion to the Appropriate Authorities on 20 September 2023.

The Defra Secretary of State with the consent of the Appropriate Authorities has 6 months from receipt of the final opinions in which to make decisions on whether to grant the authorisations.

The opinions and other related documentation can be found on the HSE website:

List of UK REACH authorisations – granted and applications in progress